Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

44.4%

4 terminated/withdrawn out of 9 trials

Success Rate

55.6%

-30.9% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

8(88.9%)

Phase 1

1(11.1%)

9Total

N/A(8)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05843721Not ApplicableTerminated

Post-marketing Clinical Follow-up for Long-term Use of Intranasal Kinetic Oscillation in Subjects With Chronic Migraine

Role: lead

NCT05273151Not ApplicableTerminated

A Study With Intranasal Kinetic Oscillation Stimulation (KOS) in the Prevention of Chronic Migraine

Role: lead

NCT03400059Not ApplicableCompleted

Study to Evaluate the Efficacy of Intranasal Kinetic Oscillation Stimulation in the Preventive Treatment of Chronic Migraine

Role: lead

NCT03399721Not ApplicableCompleted

Investigation of Kinetic Oscillation Stimulation by the Chordate System S101 in the Treatment of Non Allergic Rhinitis

Role: lead

NCT02243865Not ApplicableCompleted

Chordate System Prophylactic Migraine Clinical Investigation

Role: lead

NCT02185703Not ApplicableTerminated

Chordate System S020 Acute Migraine Clinical Investigation

Role: lead

NCT01844336Not ApplicableCompleted

PBASE System Idiopathic Rhinitis Clinical Investigation

Role: lead

NCT01680029Not ApplicableTerminated

PBASE-system Acute Migraine Clinical Investigation

Role: lead

NCT01798368Phase 1Completed

PBASE-system Safety and Tolerability Clinical Investigation

Role: lead

All 9 trials loaded